Abstract
To ensure that experiences and lessons learned from the unprecedented 2011 Great East Japan Earthquake are used to improve future disaster planning, the Japan Diabetes Society (JDS) launched the “Research and Survey Committee for Establishing Disaster Diabetes Care Systems Based on Relevant Findings from the Great East Japan Earthquake” under the supervision of the Chairman of the JDS. The Committee conducted a questionnaire survey among patients with diabetes, physicians, disaster medical assistance teams (DMATs), nurses, pharmacists, and nutritionists in disaster areas about the events they saw happening, the situations they found difficult to handle, and the needs that they felt required to be met during the 2011 Great East Japan Earthquake. A total of 3,481 completed questionnaires were received. Based on these and other experiences and lessons reported following the 2011 Great East Japan Earthquake and the 2004 Niigata-Chuetsu Earthquakes, the current “Manual for Disaster Diabetes Care” has been developed by the members of the Committee and other invited authors from relevant specialties. To our knowledge, the current Manual is the world’s first to focus on emergency diabetes care, with this digest English version translated from the Japanese original. It is sincerely hoped that patients with diabetes and healthcare providers around the world will find this manual helpful in promoting disaster preparedness and implementing disaster relief.
Similar content being viewed by others
Abbreviations
- ACS:
-
Acute coronary syndrome
- AKI:
-
Acute kidney injury
- AP:
-
Angina pectoris
- ASD:
-
Acute stress disorder
- CCB:
-
Calcium channel blocker
- CDEJ:
-
Certified Diabetes Educator of Japan
- CF:
-
Cardiac failure
- CI:
-
Cerebral infarction
- CSII:
-
Continuous subcutaneous insulin infusion
- CVD:
-
Cardiovascular disease
- DiaMAT:
-
Diabetes medical assistance team
- DPP-4:
-
Dipeptidyl peptidase-4
- DVT:
-
Deep vein thrombosis
- EMR:
-
Electronic medical records
- GLP-1:
-
Glucagon-like peptide-1
- IHD:
-
Ischemic heart disease
- IT:
-
Information technology
- JMAT:
-
Japan Medical Association team
- MAS:
-
Medical aid stations
- MI:
-
Myocardial infarction
- NVG:
-
Neovascular glaucoma
- PD:
-
Panic disorder
- PE:
-
Pulmonary embolism
- PT-INR:
-
The prothrombin time/international normalized ratio
- PTSD:
-
Posttraumatic stress disorder
- RAS:
-
The renin–angiotensin system
- RD:
-
Retinal detachment
- SD:
-
Standard deviation
- SGLT2:
-
Sodium glucose co-transporter 2
- SNS:
-
Social network services
- SUs:
-
Sulfonylureas
- TZD:
-
Thiazolidinedione
- α-GI:
-
α-Glucosidase inhibitor
References
Kadowaki T. Condolences for the victims of the Tohoku Pacific Ocean Earthquake and report of the Japan Diabetes Society disaster relief activities (in Japanese). http://www.fa.kyorin.co.jp/jds/uploads/photos/716.pdf. Accessed 22 March 2019.
Report Timely. Diabetes treatment in times of disaster. J Jpn Diabetes Soc. 2011;54:657–74 (in Japanese).
Report Timely. Comprehensive team medicine in times of disaster. J Jpn Diabetes Soc. 2011;54:713–31 (in Japanese).
Japan Diabetes Society. Report of questionnaire survey results. Research and surveys for establishing disaster diabetes care systems based on relevant findings from the Great East Japan Earthquake. The Japan Diabetes Society 2012 (in Japanese).
Yamamoto Y. Preparing for future Tokai, Tonankai, and Nankai earthquakes in anticipation of unprecedented, extremely broad-based earthquakes. Jpn J Diabetic Caring. 2008;5:82–5 (in Japanese).
Nakahara I, et al. Present state of risk management in insulin treatment for type 1 diabetic patients and its renovation. J Jpn Diabetes Soc. 2004;47:395–7 (in Japanese).
Kumasaka Y. Diabetes medical care in the community at the time of disaster. J Jpn Diabetes Soc. 2011;54:668–9 (in Japanese).
Asakura T, et al. About the influence of air mixing on concentration and precision of the injection of the injection device: the negative influence of storing a device with the needle attached. J Jpn Diabetes Soc. 2007;50:877–82 (in Japanese).
Asakura T, et al. Alternation of insulin preparations and insulin injection devices by freezing and thawing for guiding diabetic patients proper insulin therapy. J Jpn Diabetes Soc. 2003;46:767–73 (in Japanese).
Hanzawa K. On the risk of pulmonary/vein thromboembolism in individuals staying in vehicles after the Niigata-Chuetsu Earthquakes: echocardiographic findings from those staying in vehicles. Ther Res. 2005;26:1207–12 (in Japanese).
Hanzawa K, et al. A medical report of the mid Niigata Prefecture Earthquake 2004: results of ultrasonography in lower leg. Niigata Med J. 2006;120:15–20 (in Japanese).
Sakuma M, et al. Acute pulmonary embolism after an earthquake in Japan. Semin Thromb Hemost. 2006;32:857–60.
Shibata M, et al. Deep venous thrombosis among disaster shelter inhabitants following the March 2011 earthquake and tsunami in Japan: a descriptive study. Phlebology. 2014;29:257–66.
Simpson K. Shelter deaths from pulmonary embolism. Lancet. 1940;2:744.
Hanzawa K. Frequency of DVT after the Niigata-Chuetsu earthquakes. Ther Res. 2008;29:641–3 (in Japanese).
Hanzawa K, et al. Frequency of DVT after the Iwate-Miyagi Nairiku (Inland) Earthquake: relationship with refugee shelter environments. Ther Res. 2009;30:572–4 (in Japanese).
Hanzawa K. Frequency of DVT and hypertension among Fukushima refugees living in refugee shelters outside Fukushima Prefecture: Relationship with refugee shelter environments. Thromb Circ. 2012;20:53–61 (in Japanese).
Ueda S, et al. High prevalence of deep vein thrombosis in Tsunami-flooded shelters established after the Great East-Japan Earthquake. Tohoku J Exp Med. 2012;227:199–202.
Shibata S, et al. Team Kurihara—venous thromboembolism prevention activities. Heart. 2010;42:473–80 (in Japanese).
Fuse I, et al. Guidelines for diagnosis and treatment of deep vein thrombosis (DVT) in residents in areas affected by the Niigata-Chuetsu Earthquake. J Niigata Med Assoc. 2006;675:2–12 (in Japanese).
Ministry of Health, Labor and Welfare Research Group, Japanese Society for Infection Prevention and Control, e Niigata-Chuetsu Earthquake. e shelter environments. g in vehicles. icle. (in Japanese). http://www.kankyokansen.org/modules/news/index.php?content_id=20. Accessed 22 March 2019.
Aoki T, et al. The Great East Japan earthquake disaster and cardiovascular diseases. Eur Heart J. 2012;33:2796–803.
Minami J, et al. Effect of the Hanshin-Awaji earthquake on home blood pressure in patients with essential hypertension. Am J Hypertens. 1997;10:222–5.
Kamoi K, et al. Effect of the 2004 Mid-Niigata Prefecture Earthquake on home blood pressure measurement in the morning in type 2 diabetic patients. Clin Exp Hypertens. 2006;28:719–29.
Tanaka K, et al. The great East Japan earthquake: blood pressure control in patients with chronic kidney disease. Am J Hypertens. 2012;25:951–4.
Kario K, et al. Factors associated with the occurrence and magnitude of earthquake-induced increases in blood pressure. Am J Med. 2001;111:379–84.
Tanaka K, et al. Home blood pressure control after the Great East Japan Earthquake in patients on chronic hemodialysis. Ther Apher Dial. 2014;18:149–54.
Giorgini P et al. Long term blood pressure change induced by the 2009 L’aquila earthquake. Assessment by 24 h ambulatory monitoring. Hypertens Res. 2013;36:795–798.
Tanaka K, et al. Aftercare for the prevention of a secondary health disaster in survivors of major earthquakes. Hypertens Res. 2013;36:759–61.
Inui A, et al. Effect of the Kobe earthquake on stress and glycemic control in patients with diabetes mellitus. Arch Int Med. 1998;158:274–8.
Fujihara K, et al. Impact of psychological stress caused by the Great East Japan Earthquake on glycemic control in patients with diabetes. Exp Clin Endocrinol Diabetes. 2012;120:560–3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest statement
Jo Satoh received honoraria from Boehringer Ingelheim, Eli Lilly and Company, MSD, Ono pharmaceutical Co., Ltd., Sanofi, and Sumitomo Dainippon Pharma Co., Ltd. Toshinari Asakura received honoraria from Novo Nordisk. TA also received research funding from Eli Lilly Japan. Kazuhiko Hanzawa received honoraria from Daiichi Sankyo Co. Yasushi Ishigaki received honoraria from MSD Ltd., Sanofi Ltd., Bayer Yakuhin Ltd., Takeda pharmaceutical Co., Novo Nordisk Pharma Ltd., Novartis Pharma Ltd., Ono pharmaceutical company, Kowa pharmaceutical Co., Ltd. YI also received subsidies/donations from MSD Ltd., Ono pharmaceutical company. Takashi Kadowaki received honoraria from MSD Corporation, Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Kowa Pharmaceutical Co., Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co., Ltd., AstraZeneca K. K., Sumitomo Dainippon Pharma Co., Ltd., Sanofi K. K., Eli Lilly Japan K. K., Nippon Boehringer Ingelheim Co. Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and Taisho Pharmaceutical Co., Ltd. TK also received research funding from MSD Corporation, Daiichi Sankyo Co., Ltd., Novo Nordisk Pharma Ltd., Sanofi K. K., and Takeda Pharmaceutical Co., Ltd. TK belongs to endowed departments by Takeda Pharmaceutical Co., Ltd., TERUMO Corporation, MSD Corporation, Novo Nordisk Pharma Ltd., and Nippon Boehringer Ingelheim Co. Ltd. Hideki Katagiri received honoraria from Astellas Pharma Inc., Daiichi-Sankyo, Taisho Toyama Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Boehringer Ingelheim, MSD K.K., and Novartis Pharma. HK also received subsidies/donations from Astellas Pharma Inc., Novo Nordisk Pharma Ltd., Takeda Pharmaceutical Company Ltd., Sanofi K.K., Daiichi-Sankyo, Eli Lilly Japan K.K., Taisho Toyama Pharmaceutical Co., Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., MSD K.K., and Novartis Pharma. Jiro Nakamura received honoraria from Astellas Pharma Inc., AstraZeneca K.K., MSD KK., Ono Pharmaceu. Co., Ltd., Daiichi Sankyo Co., Ltd., Kowa Pharmaceu, Co., Ltd., Sanofi K.K., Takeda Pharmaceu. Co., Ltd., Mitsubishi Tanabe Pharma Corp., Terumo Co., Boehringer Ingelheim Japan Co., Ltd., Eli Lilly Japan K.K., Novartis Pharma K.K., and Novo Nordisk Pharma Ltd. JN also received research funding from Kissei Pharmaceu. Co., Ltd., Boehringer Ingelheim Japan Co., Ltd., and EPS Co., Ltd. JN also received subsidies/donations from Astellas Pharma Inc., MSD K.K., Ono Pharmaceu. Co., Ltd., Sanofi K.K., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceu. Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceu. Co., Ltd., Eli Lilly Japan K.K., Japan Tobacco Inc., Novartis Pharma K.K., and Novo Nordisk Pharma Ltd. Shigeru Sakurai received subsidies/donations from Philips-Respironics Co., Ltd. Hiroaki Tomita received subsidies/donations from Kodama Hospital and Medical Corporation Association Zao-kai. Hironori Waki received subsidies/donations from Sanofi K.K. and Novo Nordisk Pharma Ltd. HW belongs to endowed departments by MSD K.K., Novo Nordisk Pharma Ltd., and Nippon Boehringer Ingelheim Co. Ltd. Koichi Yokono, Rie Ando, Masato Kasuga, Yasuhisa Kato, Koreyuki Kurosawa, Masanobu Miura, Koichi Nishitsuka, Susumu Ogawa, Tomoko Okamoto, Sadanori Sakuma, Hiroaki Satoh, Hidetoshi Shimauchi, Hiroaki Shimokawa, Wataru Shoji, Takashi Sugiyama, Akira Suwabe, Masahiro Tachi, Kazuma Takahashi, Susumu Takahashi, Yasuo Terayama, Yoko Tsuchiya, Tsuyoshi Watanabe, Kazuaki Yahata, Hidetoshi Yamashita declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Jo Satoh, Koichi Yokono, Rie Ando, Yasushi Ishigaki, Hideki Katagiri, Hiroaki Satoh, Kazuma Takahashi, Yoko Tsuchiya, Tsuyoshi Watanabe, and Kazuaki Yahata are the members of Research and Survey Committee for Establishing Disaster Diabetes Care Systems Based on Relevant Findings from the Great East Japan Earthquake.
Takashi Kadowaki is the Board of Directors, the Japan Diabetes Society.
Masato Kasuga is Academic Investigation and Education, the Japan Diabetes Society.
About this article
Cite this article
Satoh, J., Yokono, K., Ando, R. et al. Diabetes care providers’ manual for disaster diabetes care. Diabetol Int 10, 153–179 (2019). https://doi.org/10.1007/s13340-019-00397-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13340-019-00397-7